
Equillium: Pushing Forward With AhR Activation Drug Candidate EQ504 For UC (NASDAQ:EQ)
This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector with years of experience utilizing his Applied Science background to generate long term value from Healthcare.